Clinical Trials on Relapsed or Refractory Solid Tumors or Lymphoma in Children in United States
Total 813 results
-
The University of Texas Health Science Center at...CompletedRefractory or Relapsed Solid TumorsUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedRelapsed or Refractory Solid TumorsUnited States
-
Children's Hospital Los AngelesCompleted
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRelapsed or Refractory Solid TumorsUnited States, Argentina, Australia, Belgium, Croatia, Czechia, France, Guatemala, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Peru, Russian Federation, Serbia, South Africa, Spain, Sweden, Turkey
-
Calgent Biotechnology Co., LtdCompletedResistant or Refractory Solid TumorsUnited States, Taiwan
-
Sidney Kimmel Comprehensive Cancer Center at Johns...RecruitingRefractory and/or Relapsed Metastatic Solid TumorsUnited States
-
Lantern Pharma Inc.RecruitingAdvanced Solid Tumor | Relapsed or Refractory LymphomasUnited States
-
BayerTerminatedOsteosarcoma | Ewing Sarcoma | Neuroblastoma | Rhabdomyosarcoma | Relapsed or Refractory Solid Tumors or Lymphoma in ChildrenUnited States
-
University of Colorado, DenverUniversity of KentuckyCompletedRefractory Solid Tumors | Relapsed Solid TumorsUnited States
-
Lupin Ltd.CompletedA Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsNRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsUnited Kingdom, Netherlands, Belgium
-
ModernaTX, Inc.TerminatedOvarian Cancer | Relapsed/Refractory Solid Tumor Malignancies or LymphomaUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedLymphoma | Refractory or Relapsed Solid TumorsKorea, Republic of, United States, Canada, Belgium, Denmark
-
OncoMed Pharmaceuticals, Inc.CompletedRefractory Solid Tumors | Advanced Relapsed TumorsUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedRelapsed or Refractory Lymphoid MalignanciesUnited States
-
Stanford UniversityAmgen; Pediatric Oncology Experimental Therapeutics Investigators' ConsortiumCompletedRefractory Leukemia | Refractory Solid Tumors | Relapsed Solid Tumors | Relapsed LeukemiaUnited States, Canada
-
Sorrento Therapeutics, Inc.RecruitingSolid Tumor | Refractory Tumor | Relapsed Solid NeoplasmUnited States
-
Kronos BioRecruitingNon-Hodgkin Lymphoma | Refractory Solid Tumors | Relapsed Solid TumorsUnited States, Spain, United Kingdom
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedPatients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is AvailableUnited States
-
Children's Hospital Medical Center, CincinnatiActive, not recruitingAdult Solid Tumor | Relapsed Cancer | Refractory Cancer | Childhood Solid Tumor | Childhood Lymphoma | Adult LymphomaUnited States
-
Alfasigma S.p.A.Terminated
-
Eisai Inc.CompletedLymphomas | Refractory Solid TumorsUnited States
-
Allogene TherapeuticsRecruitingRelapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic LymphomaUnited States, Spain, Canada, Australia, Italy
-
Erimos PharmaceuticalsTerminatedLymphoma | Refractory Solid TumorsUnited States
-
HutchmedCompleted
-
Ehab L AtallahTerminatedRelapsed or Refractory Acute Lymphoblastic Leukemia | Mixed Phenotype Acute Leukemia | Relapsed or Refractory Lymphoblastic LymphomaUnited States
-
HutchmedCompleted
-
HutchmedCompletedRelapsed or Refractory LymphomaUnited States
-
HotSpot Therapeutics, IncRecruitingSolid Tumor, Adult | Relapsed Cancer | Refractory CancerUnited States
-
Nektar TherapeuticsCompletedAdvanced or Metastatic Solid Tumors in Patients With Hepatic ImpairmentUnited States
-
St. Jude Children's Research HospitalNovartis PharmaceuticalsCompletedRecurrent or Refractory Solid Tumors | CNS MalignanciesUnited States
-
Curis, Inc.The Leukemia and Lymphoma SocietyCompletedLymphoma | Refractory Lymphoma | Relapsed Lymphoma | Relapsed and/or Refractory Lymphoma | Relapsed Ddiffuse Large B-Cell Lymphoma (DLBCL) | Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Double-hit Lymphoma (DHL) | Triple-hit Lymphoma... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterPharmacyclics LLC.; Janssen Biotech, Inc.RecruitingAdult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL) | Or Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)United States
-
Hoffmann-La RocheCompletedRelapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell LymphomaUnited States, Spain, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Relapsed/Refractory LymphomaUnited States
-
Synta Pharmaceuticals Corp.CompletedAdvanced or Metastatic Solid TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterChugai Pharma USARecruitingPrimary Extra-cranial Solid Tumor | Recurrent or Refractory Glypican 3 (GPC3)United States
-
Chinook Therapeutics, Inc. (formerly Aduro)Novartis PharmaceuticalsTerminatedAdvanced/Metastatic Solid Tumors or LymphomasUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed or Refractory Hodgkin Lymphoma | Relapsed or Refractory Anaplastic Large-cell LymphomaUnited States, France, United Kingdom, Germany, Spain, Netherlands, Italy, Mexico
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Relapsed/Refractory LymphomaUnited States
-
Children's Oncology GroupCompletedRefractory or Recurrent Solid Tumors, Excluding CNS TumorsUnited States, Canada
-
DynamiCure BiotechnologyTerminatedAdvanced or Metastatic Solid TumorsUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Incendia TherapeuticsRecruitingAdvanced or Metastatic Solid TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of NebraskaCompletedT-cell Lymphomas | Relapsed or RefractoryUnited States
-
Taiho Oncology, Inc.TerminatedAdvanced or Metastatic Solid Tumors Irrespective of Gene Alterations | Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating MutationsUnited States, United Kingdom, Austria, France
-
Pyrotech Therapeutics, Inc.RecruitingLocally Advanced or Metastatic Solid TumorsUnited States
-
Autolus LimitedRecruitingRelapsed or Refractory B Cell Acute Lymphoblastic Leukemia | Relapsed or Refractory B Cell Non-Hodgkin LymphomaUnited Kingdom
-
Erasca, Inc.Active, not recruitingAdvanced or Metastatic Solid TumorsUnited States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Non-Hodgkin Lymphoma | Relapsed or Refractory Chronic Lymphocytic LeukemiaUnited Kingdom, Spain, France, Australia
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic or Locally Advanced Unresectable Solid TumorsUnited States